Work

Supplemental Figure 8 from Myosin light chain kinase inhibition potentiates the anti-tumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor

Year: 2024

Type: supplementary-materials

Abstract: Supplemental Figure 8. Relative MYLK mRNA expression by qPCR in GIST PDGFRA D842V PDXs treated with vehicle (Veh) or imatinib (IM) for 2 weeks.

DOI: 10.1158/1078-0432.27030499.v1

Authors: Ferdinand Rossi, Mengyuan Liu, Andrew Tieniber, Mark S. Etherington, Andrew Hanna, Gerardo A. Vitiello, Nesteene J. Param, Kevin Do, Laura Wang, Cristina R. Antonescu, Shan Zeng, Jennifer Q. Zhang, Ronald P. DeMatteo

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4402800766

Cites:

Cited by:

Related to: 10